Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 132 for Epilepsy

Edit search filters
  1. Study Evaluating the Safety and Efficacy of Fenfluramine Hydrochloride Oral Solution as Adjunctive Therapy in Children with Doose Syndrome

    Rochester, MN

  2. A Study to Evaluate Patients with Dravet Syndrome Who Previously Participated in Studies of STK-001

    Rochester, MN

  3. Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies (PACIFIC)

    Rochester, MN

  4. High Frequency Oscillations in Neurologic Disease

    Rochester, MN

  5. A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

    Rochester, MN

  6. A Study to Evaluate Feasibility of Microburst Vagus Nerve Stimulator (VNS) Therapy

    Jacksonville, FL

  7. Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)

    Rochester, MN

  8. Antineuronal Antibody Positivity Prevalence and Predictors in Epilepsy With Different Risks of Autoimmune Epilepsy

    Rochester, MN

  9. Network Neuro-modulation for Mesial Temporal Lobe Epilepsy

    Rochester, MN

  10. A Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer’s Disease

    Jacksonville, FL

.

Mayo Clinic Footer